General Oncology, Inc.
Pharmaceuticals · Newton, MA
PharmaceuticalsSEC Form D
General Oncology, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 23, 2026, reporting $4,805,299 raised.
Incorporated in Delaware and based in Newton, MA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that General Oncology, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Jeffrey Aaron GlazierExecutive Officer · Director
- Arnold GlazierExecutive Officer · Director
- Abid AnsariExecutive Officer
- Michael J. PetitDirector
- Barry SeemanDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$384.8KRaised
Spine BioPharma, Inc.
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised